GlassScriptPhysician profile
Kaitlyn M Leone
NPI 1861944050
$998.03
in general payments reported to CMS, 2019-2025
17 companies · $739 in 2025
The $739 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2022: $63.74 · 2024: $80.07 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $178.74 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.76 | 2024-2025 | Trintellix |
| Lundbeck LLC | $93.71 | 2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $86.67 | 2025 | Fanapt, Hetlioz |
| Otsuka America Pharmaceutical, INC. | $83.85 | 2025 | Rexulti, Abilify Asimtufii |
| Abbvie INC. | $81.67 | 2024-2025 | |
| Axsome Therapeutics, INC. | $66.39 | 2025 | Auvelity |
| Neurocrine Biosciences, INC. | $61.23 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $45.63 | 2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $41.53 | 2025 | Austedo Xr |
| Collegium Pharmaceutical, INC. | $38.85 | 2025 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $27.07 | 2025 | Spravato |
| Ironshore Pharmaceuticals INC. | $24.82 | 2024 | |
| Harmony Biosciences LLC | $22.99 | 2024 | |
| Alkermes, INC. | $19.91 | 2025 | Lybalvi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $16.57 | 2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $13.64 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlyn Leone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.